generalized pustular psoriasis

Washington, D.C., August 24, 2026 Vanda Pharmaceuticals Inc. announced that the European Commission has granted Orphan Designation to imsidolimab...

WASHINGTON, May 27, 2026 Vanda Pharmaceuticals Inc. has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...

WASHINGTON, April 28, 2026 Vanda Pharmaceuticals Inc. has announced the publication of pivotal Phase III clinical data evaluating imsidolimab,...